Related Experiment Video
Updated: Jan 9, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Interleukin-1 Inhibitors for Management of Recurrent Pericarditis After Thoracic Organ Transplantation
Bijal Rajput1, Arushi Singh2, Michael S Garshick3
1Department of Internal Medicine, New York University Grossman School of Medicine, New York, New York, USA.
Interleukin-1 inhibitors show promise for recurrent pericarditis. This study explores rilonacept use in transplant patients, highlighting infection risks and immunosuppression management in this complex group.
Area of Science:
- Cardiology
- Immunology
- Transplantation Medicine
Background:
- Recurrent pericarditis is a debilitating condition.
- Interleukin-1 inhibitors are increasingly used for recurrent pericarditis.
- Limited data exists on their use post-thoracic organ transplantation.
More Related Videos
06:15Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Related Concept Videos
Pericarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis IV: Nursing Management
Pericarditis I: Introduction
Endocarditis III: Medical Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...